PEITHO: Persuasive for thrombolysis in PE?

The largest trial ever conducted in the setting of intermediate-risk pulmonary embolism indicates that a bolus of thrombolytic therapy with tenecteplase may be of benefit in those younger than 75. In older patients, it would seem the risks outweigh the benefits.
Source: theHeart.org - Category: Cardiology Source Type: news